FDA Warning Letter to J&J's Abiomed Has Broad Implications for Medtech

Retrieved on: 2023-10-17 16:16:32

Tags for this article:

Click the tags to see associated articles and topics

FDA Warning Letter to J&J's Abiomed Has Broad Implications for Medtech. View article details on hiswai:

Excerpt

This should be of particular interest to companies that make wearable medical devices or patient monitoring technologies. "Abiomed's FDA warning ...

Article found on: www.mddionline.com